Status: Recruiting
Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis
This ambispective observational study aims to validate the Odesa Criteria 2026 (OC26), a flexible domain-based point scoring system for diagnosing autoimmune pancreatitis. The study evaluates diagnostic accuracy and reproducibility of OC26 across clinical, serological, morphological, and histological domains.
Participants needed: 82
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Military Medical Clinical Center of the Southern Region, UkraineUpdated: May 28, 2026Locations: 2
Eligibility criteria
Adults (≥18 years) undergoing evaluation for suspected autoimmune pancreatitis. [+2]
Confirmed alternative diagnosis explaining pancreatic findings (e.g., pancreatic... [+2]